Patent application number | Description | Published |
20090118122 | ENETRANT TRANSFER PRINTING - A penetrant transfer printing method includes the step of: providing an object with a printing layer thereon, and then providing a colorless surface material on the printing layer of the object for baking to form a protective film on the printing layer of the object, and then attaching a transfer paper on the printing layer of the object for hot pressing the transfer paper. The protective film will form pores therein because of expansion of a molecule structure, and a printing ink of a pattern on the transfer paper will be molten and penetrate into the pores of the protective film to transfer the pattern of the transfer paper to the printing layer of the object. Last step of the present is peeling the transfer paper off and clearing the object. | 05-07-2009 |
20090188619 | METHOD OF MAKING MOUSE PAD - The present invention provides a method of making a mouse pad, which mainly includes heating and pressing a fiber fabric on a surface of the mouse pad to form the fiber fabric with a flat layer and a fiber layer, and then printing pattern on the flat layer of the fiber fabric to get the mouse pad with a clear pattern. | 07-30-2009 |
20090189305 | METHOD OF MAKING FLEXIBLE FOAMING MEMBER FROM RECYCLED MATERIALS - The present invention provides a method of making a flexible foaming member from recycled material. The first step is recycling wastes including rubber, plastic, fiber, and metal, and then crushing the wastes into pieces. Next, the pieces are separated according to specific weights of each of the pieces into a plurality of groups, and then choose predetermined groups of the pieces in a predetermined ration, and mixing the pieces with a flexible material and a foaming agent to form a mixture. The last step is pressing the mixture into a plate-like foaming material, and vulcanizing the foaming material to form a flexible foaming member. The chosen groups of the pieces and the ratio thereof may make a flexible foaming member with specific property. | 07-30-2009 |
20120214884 | METHOD OF MAKING FLEXIBLE FOAMING MEMBER FROM RECYCLED MATERIALS - The present invention provides a method of making a flexible foaming member from recycled material. The present invention relates to a production method to recycling wastes containing rubber, plastic and metal materials and pulverize them into scraps under normal temperatures, then roughly separate the various materials contained in the waste scraps into different layers based on the difference of specific gravity, and further take out the scraps of rubber and plastic materials with lower specific gravity from the waste scraps, then conduct multiple heating and pulverizations under different temperatures to produce composite-material scraps, and then using some composite-material scraps to mix flexible materials and foaming agents, then pressing the mixture into a plate-like foaming material, and conduct vulcanization and foam forming for the plates of foam material to become a elastic foam. | 08-23-2012 |
20130014884 | METHOD FOR MAKING SQUARE RUGS FROM RECYCLED MATERIALSAANM KAO; SemiAACI Huatan TownshipAACO TWAAGP KAO; Semi Huatan Township TW - The present invention relates to provide a method for making square rugs from recycled materials. Firstly, make one piece of surface material: Melt the woven layer of the surface material at a proper temperature. Then, apply a proper pressure to press the surface material till each fluff of the surface material is firmly secured to the woven layer. After that, make one piece of base material and one piece of middle material made of the resilient foam material reclaimed from abandoned waste. Apply a proper pressure to press the base material, the middle material and the surface material till they are stuck on each other. Heat the stuck surface material, the middle material and the base material. The middle material will foam after heating, and produce a force to stick itself on the surface material and the base material. Thus, a square rug is finished. | 01-17-2013 |
Patent application number | Description | Published |
20110065176 | HUMAN MONOCLONAL ANTIBODY NEUTRALIZING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND USE THEREOF - The present invention relates to human monoclonal antibodies neutralizing vascular endothelial growth factor receptor and the use thereof. More specifically, relates to human ScFv molecules neutralizing vascular endothelial growth factor receptor, and a composition for inhibiting angiogenesis and a composition for treating cancer, which contain the human ScFv molecules. The disclosed monoclonal antibody neutralizing vascular endothelial growth factor receptor shows excellent neutralizing ability in living cells, compared to that of a commercially available antibody against vascular endothelial growth factor receptor, and shows the ability to neutralize vascular endothelial growth factor receptor not only in humans, but also in mice and rats. Thus, the monoclonal antibody will be useful in anticancer studies and will be highly effective in cancer treatment. | 03-17-2011 |
20120201838 | METHOD FOR SCREENING ANTICANCER AGENT OR SIP1/ZEB2 INHIBITOR USING INTEGRIN ALPHA 5 - The present invention relates to a method for screening anticancer agent or SIP1/ZEB2 inhibitor using integrin alpha 5 (ITGA5), more precisely a method for measuring integrin alpha 5 expression pattern in SIP1/ZEB2 over-expressing cell line or SIP1/ZEB2 expression induced cell line, both treated with sample compounds, by comparing with that of the control. The method of the present invention facilitates screening of anticancer agent or SIP1/ZEB2 inhibitor simply by measuring integrin alpha 5 expression, so that it can be effectively applied in the field of medicine. | 08-09-2012 |
20130108652 | ASTHMA DIAGNOSIS USING THE NEUROPILIN-1 GENE, AND METHOD FOR SCREENING FOR A THERAPEUTIC AGENT FOR ASTHMA | 05-02-2013 |
20130202560 | PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION AND TREATMENT CONTAINING THE C12ORF59 GENE OR PROTEIN AS AN ACTIVE INGREDIENT - As explained hereinbefore, the C12orf59 gene of the present invention suppresses cancer cell invasion and inhibits cancer cell survivability, and the over-expression of C12orf59 protein or a fragment thereof inhibits cancer cell invasion, so that C12orf59 gene or a fragment thereof not only can be effectively used for the pharmaceutical composition for preventing and treating cancer but also can be used as a clinical marker for screening a cancer treatment agent candidate, for diagnosing various cancers or for predicting pathological stage. In addition, the C12orf59 gene or a fragment thereof of the present invention can be used for the method for preventing and treating cancer and for the preparation of a pharmaceutical composition for preventing and treating cancer. | 08-08-2013 |
20130244959 | Composition Containing Styraxlignolide A or the Aglycone Thereof as an Active Ingredient for Preventing or Treating Asthma - The present invention relates to a pharmaceutical composition for preventing or treating asthma, the composition containing styraxlignolide A or an aglycone thereof as an active ingredient. More particularly, styraxlignolide A compound is one separated from stems and barks of | 09-19-2013 |
20140221411 | 2-HYDROXYARYLAMIDE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREOF, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER CONTAINING SAME AS ACTIVE INGREDIENT - The present invention relates to a 2-hydroxyarylamide derivative or a pharmaceutically acceptable salt thereof, a preparation method thereof, and a pharmaceutical composition for preventing or treating cancer comprising the same as an active ingredient. The 2-hydroxyarylamide derivative prepared by the present invention is excellent in the inhibition of the activity of TMPRSS4 serine protease and the suppression of the infiltration of TMPRSS4-expressed cancer cells, and thus can be useful as a composition for preventing or treating cancer by inhibiting TMPRSS4 over-expressed in cancer cells, particularly, colorectal cancer, lung cancer, breast cancer, prostate cancer, ovarian cancer, pancreatic cancer, or stomach cancer cells. | 08-07-2014 |
20140275488 | HUMAN MONOCLONAL ANTIBODY NEUTRALIZING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND USE THEREOF - The present invention relates to human monoclonal antibodies neutralizing vascular endothelial growth factor receptor and the use thereof. More specifically, relates to human ScFv molecules neutralizing vascular endothelial growth factor receptor, and a composition for inhibiting angiogenesis and a composition for treating cancer, which contain the human ScFv molecules. The disclosed monoclonal antibody neutralizing vascular endothelial growth factor receptor shows excellent neutralizing ability in living cells, compared to that of a commercially available antibody against vascular endothelial growth factor receptor, and shows the ability to neutralize vascular endothelial growth factor receptor not only in humans, but also in mice and rats. Thus, the monoclonal antibody will be useful in anticancer studies and will be highly effective in cancer treatment. | 09-18-2014 |
20140288274 | HUMAN MONOCLONAL ANTIBODY NEUTRALIZING VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR AND USE THEREOF - The present invention relates to human monoclonal antibodies neutralizing vascular endothelial growth factor receptor and the use thereof. More specifically, relates to human ScFv molecules neutralizing vascular endothelial growth factor receptor, and a composition for inhibiting angiogenesis and a composition for treating cancer, which contain the human ScFv molecules. The disclosed monoclonal antibody neutralizing vascular endothelial growth factor receptor shows excellent neutralizing ability in living cells, compared to that of a commercially available antibody against vascular endothelial growth factor receptor, and shows the ability to neutralize vascular endothelial growth factor receptor not only in humans, but also in mice and rats. Thus, the monoclonal antibody will be useful in anticancer studies and will be highly effective in cancer treatment. | 09-25-2014 |
20150259385 | PHARMACEUTICAL COMPOSITION FOR CANCER PREVENTION AND TREATMENT CONTAINING PEPTIDE ORIGINATED FROM C12ORF59 PROTEIN AS AN ACTIVE INGREDIENT - As explained hereinbefore, the C12orf59 gene of the present invention suppresses cancer cell invasion and inhibits cancer cell survivability, and the over expression of C12orf59 protein or a fragment thereof inhibits cancer cell invasion, so that C12orf59 gene or a fragment thereof not only can be effectively used for the pharmaceutical composition for preventing and treating cancer but also can be used as a clinical marker for screening a cancer treatment agent candidate, for diagnosing various cancers or for predicting pathological stage. In addition, the C12orf59 gene or a fragment thereof of the present invention can be used for the method for preventing and treating cancer and for the preparation of a pharmaceutical composition for preventing and treating cancer. | 09-17-2015 |
Patent application number | Description | Published |
20150039318 | APPARATUS AND METHOD FOR SELECTING CONTROL OBJECT THROUGH VOICE RECOGNITION - There are provided an apparatus and a method for selecting a control object through voice recognition. The apparatus for selecting a control object according to the present invention that is an apparatus for selecting a control object through voice recognition includes one or more processing devices, in which the one or more processing devices are configured to obtain input information on the basis of a voice of a user, to match the input information to at least one identification information obtained based on a control object, to obtain matched identification information matched to the input information among the identification information, and to select a control object corresponding to the matched identification information. | 02-05-2015 |
20150073801 | APPARATUS AND METHOD FOR SELECTING A CONTROL OBJECT BY VOICE RECOGNITION - There are provided an apparatus and a method for selecting a control object through voice recognition. The apparatus for selecting a control object through voice recognition according to the present invention includes one or more processing devices, in which the one or more processing devices are configured to obtain input information on the basis of a voice of a user, to match the input information to at least one first identification information obtained based on a control object and second identification information corresponding to the first identification information, to obtain matched identification information matched to the input information within the first identification information and the second identification information, and to select a control object corresponding to the matched identification information. | 03-12-2015 |
20150088524 | APPARATUS AND METHOD FOR GENERATING AN EVENT BY VOICE RECOGNITION - There are provided an apparatus and a method for generating an event through voice recognition. The apparatus for generating an event through voice recognition according to the present invention includes one or more processing devices, in which the one or more processing devices are configured to obtain input information on the basis of a voice of a user, to match the input information to at least one identification information obtained based on application screen information, to obtain matched identification information matched to the input information among the identification information, and to generate an event in at least a partial area of areas corresponding to the matched identification information. | 03-26-2015 |